Farringdon Capital’s Halozyme HALO Stock Holding History

Farringdon Capital’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,922	Closed	-$361K	–	515
2025 Q3	$361K	Sell	4,922 -4,127	-46%	-$274K	0.09%	297
2025 Q2	$471K	Buy	+9,049	New	+$515K	0.16%	212

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Farringdon Capital's HALO Position: Q4 2025 in Review

Farringdon Capital sold out of Halozyme (HALO) in Q4 2025, closing a stake of 4,922 shares — an estimated $361K sold.

Farringdon Capital first reported a position in HALO in Q2 2025 and held it in 2 quarters. The position peaked at $471K in Q2 2025. 617 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

Farringdon Capital reported no remaining Halozyme position as of Q4 2025 after selling out during the quarter.
Farringdon Capital sold 4,922 Halozyme shares in Q4 2025, an estimated $361K.
Farringdon Capital first reported a position in Halozyme in Q2 2025 and held it in 2 quarters.
Farringdon Capital's Halozyme position peaked at $471K in Q2 2025.
617 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on Farringdon Capital's 13F filing for Q4 2025, filed 17 Feb 2026.